Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Nebraska
M.D. Anderson Cancer Center
University of California, Davis
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Children's Oncology Group
University of Arizona
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Stanford University
Children's Oncology Group
Fred Hutchinson Cancer Center
Chung-Ang University
Children's Oncology Group
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center